Answers are grounded in this paper and cite their sources.
Investigates pathogenic therapy approaches in frontotemporal lobar degeneration, suggesting new treatment options.
The article describes a fast-acting, high-efficiency cell model that provides an invaluable screening tool to accelerate targeted therapies directly preventing the toxic accumulation of truncated TDP43 protein forms driving Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
No takes yet. Share an insight, caveat, or question.
Kukharsky et al. (2013) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: